
July 23, 2026
Celebrating 10 years of CAR T-cell therapy at UNC Health
Roy Dreyfuss received CAR T-cell therapy for Hodgkin lymphoma as part of a clinical trial in 2016. This was more than a year before the FDA approved this treatment for other blood cancers; Dreyfuss became the first patient to receive CAR T-cell therapy at UNC Health.







